Evidence map›Paper›PMID 34683560›Full record

ReviewMaterials (Basel, Switzerland)2021

Potentiality of Nanoenzymes for Cancer Treatment and Other Diseases: Current Status and Future Challenges.

Rakesh K Sindhu, Agnieszka Najda, Prabhjot Kaur, Muddaser Shah, Harmanpreet Singh, Parneet Kaur, Simona Cavalu, Monika Jaroszuk-Sierocińska, Md Habibur Rahman

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Trojan Horse Strategy: How Biomimetic Nanomedicine Remodels the Tumor Microenvironment.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. V-doped MoSFrontiers in pharmacology · 2024
    Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rakesh K SindhuChitkara College of Pharmacy, Chitkara University, Punjab 140401, India.ORCID 0000-0003-2619-4643
Agnieszka NajdaDepartment of Vegetable Crops and Medicinal Plants, University of Life Sciences in Lublin, 50A Doświadczalna St., 20-280 Lublin, Poland.ORCID 0000-0002-1185-8884
Prabhjot KaurChitkara College of Pharmacy, Chitkara University, Punjab 140401, India.
Muddaser ShahDepartment of Botany, Abdul Wali Khan University Mardan, Mardan 23200, Pakistan.ORCID 0000-0001-8839-4419
Harmanpreet SinghChitkara College of Pharmacy, Chitkara University, Punjab 140401, India.ORCID 0000-0003-0142-6655
Parneet KaurChitkara College of Pharmacy, Chitkara University, Punjab 140401, India.
Simona CavaluFaculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania.ORCID 0000-0001-7810-8925
Monika Jaroszuk-SierocińskaInstitute of Soil Science and Environment Shaping, University of Life Sciences in Lublin, 7 Leszczyńskiego St., 20-069 Lublin, Poland.
Md Habibur RahmanDepartment of Pharmacy, Southeast University, Banani, Dhaka 1213, Bangladesh.ORCID 0000-0001-6099-5693

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Studies from past years have observed various enzymes that are artificial, which are issued to mimic naturally occurring enzymes based on their function and structure. The nanozymes possess nanomaterials that resemble natural enzymes and are considered an innovative class. This innovative class has achieved a brilliant response from various developments and researchers owing to this unique property. In this regard, numerous nanomaterials are inspected as natural enzyme mimics for multiple types of applications, such as imaging, water treatment, therapeutics, and sensing. Nanozymes have nanomaterial properties occurring with an inheritance that provides a single substitute and multiple platforms. Nanozymes can be controlled remotely via stimuli including heat, light, magnetic field, and ultrasound. Collectively, these all can be used to increase the therapeutic as well as diagnostic efficacies. These nanozymes have major biomedical applications including cancer therapy and diagnosis, medical diagnostics, and bio sensing. We summarized and emphasized the latest progress of nanozymes, including their biomedical mechanisms and applications involving synergistic and remote control nanozymes. Finally, we cover the challenges and limitations of further improving therapeutic applications and provide a future direction for using engineered nanozymes with enhanced biomedical and diagnostic applications.

Indexed as

artificialbiomedicalcancer diagnosisnanomaterialsnanozymestherapeutics

Identifiers

PMID34683560
PMCPMC8539628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.